Search results (46)
« Back to All PublicationsTracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis
Journal article
Gupta T. et al, (2024), Cancer Cell, 42, 797 - 814.e15
Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity
Journal article
Hamid MHBA. et al, (2024), Nature Immunology, 25, 834 - 846
Proximity proteomics reveals UCH-L1 as an essential regulator of NLRP3-mediated IL-1β production in human macrophages and microglia
Journal article
Liang Z. et al, (2024), Cell Reports, 43, 114152 - 114152
TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathways
Journal article
Chan W. et al, (2023), Journal of Experimental Medicine, 220
Proximity proteomics reveals UCH-L1 as an NLRP3 interactor that modulates IL-1β production in human macrophages and microglia
Preprint
Liang Z. et al, (2023)
A robust deep learning workflow to predict CD8 + T-cell epitopes
Journal article
Lee CH. et al, (2023), Genome Medicine, 15
Can we predict T cell specificity with digital biology and machine learning?
Journal article
Hudson D. et al, (2023), Nature Reviews Immunology, 23, 511 - 521
Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides
Journal article
Yang X. et al, (2022), Nature, 612, 771 - 777
Structure of a fully assembled tumor-specific T cell receptor ligated by pMHC
Journal article
Sušac L. et al, (2022), Cell, 185, 3201 - 3213.e19
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
Journal article
Lanz TV. et al, (2022), Nature, 603, 321 - 327
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
Journal article
Theruvath J. et al, (2022), Nature Medicine, 28, 333 - 344
Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM
Preprint
Lanz TV. et al, (2022)
RTN4/NoGo-receptor binding to BAI adhesion-GPCRs regulates neuronal development
Journal article
Wang J. et al, (2022), Cell, 185, 218 - 218
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
Journal article
Peng Y. et al, (2022), Nature Immunology, 23, 50 - 61